Merck Health Innovation Fund

Merck Global Health Innovation Fund (MGHIF) is the corporate venture capital arm of Merck & Co., specializing in digital health and health technology investments. Established in 2010, the fund manages over $500 million and operates as an evergreen vehicle, reinvesting returns into new opportunities. MGHIF targets growth-stage companies that offer innovative solutions in personalized medicine, health information technology, and care management. By providing strategic capital and access to Merck's global clinical and commercial expertise, the fund aims to accelerate the adoption of technologies that improve patient outcomes. MGHIF is recognized as one of the most active and influential investors in the digital health space, bridging the gap between traditional biopharma and modern technology.